SAILIFE price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- SAILIFE
- MB Code
- MBEQU1863
- ISIN
- INE570L01029
- BSE code
- 544306
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 602.14 Cr
- Net profit
- 104.24 Cr
- EPS
- 4.87
- YoY revenue
- +3.91%
Company documents
10 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for SAILIFE
Sai Life Sciences reported Q4 2026 earnings with strong revenue and profit growth, alongside plans for sizeable capex to expand operation…
EPS 4.86 vs est. 5.05
Missed estimates by 3.74%
Sai Life Sciences shared multiple investor updates, including Q4/FY26 audited results on 31 March 2026, an earnings call transcript, inve…
Sai Life Sciences shares surged over 8% following an impressive 86% year-on-year increase in Q3FY26 net profit, attributed to robust reve…
EPS 5.10 vs est. 3.77
Beat estimates by 35.14%
EPS 3.93 vs est. 2.86
Beat estimates by 37.61%
Sai Life Sciences shares rose 5% as 20.95 million shares were traded on BSE, indicating significant market activity. Check for block deal…
TPG Asia plans to sell shares of Sai Life Sciences valued at Rs 850 crore through a block deal, as reported by CNBC-Awaaz.
Price returns
Historical performance
Technicals
Indicator consensus